(Q81927273)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Adjuvant and salvage treatment after radical prostatectomy: current practice in the UK (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Richard A. Cowan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

L W Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

V A C Ramani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

J P Wylie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

J P Logue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

13 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

229-234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500816

13 January 2020

exact match

0 references

cites work

Recent trends in the use of radical prostatectomy in England: the epidemiology of diffusion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500816

7 January 2021

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500816

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500816

7 January 2021

Evaluation and management of men whose radical prostatectomies failed: results of an international survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500816

7 January 2021

Initiation of salvage therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500816

7 January 2021

What to do for prostate cancer patients with a rising PSA?--A survey of Australian practice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500816

7 January 2021

Contemporary management of prostate cancer: a practice survey of Ontario genitourinary radiation oncologists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500816

7 January 2021

Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500816

7 January 2021

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500816

7 January 2021

Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500816

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500816

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15999120%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference